Thoropass vs Cursor
Side-by-side comparison of AI visibility scores, market position, and capabilities
$98M funding ($50M Series C Jan 2024 Fin Capital); $60.4M revenue 2024; 232 employees; Inc. 5000 #427 2024; G2 Leader Summer 2025 (6 categories); SOC2/ISO27001 leader
About
Thoropass is a compliance automation platform founded to eliminate the manual audit burden that prevents fast-growing companies from achieving security certifications such as SOC 2, ISO 27001, HIPAA, and PCI DSS. The company was founded on the premise that compliance should be a continuous, automated process integrated into engineering workflows rather than a periodic, documentation-heavy audit exercise performed by consultants. Thoropass combines purpose-built compliance software with in-house auditors, offering customers a single vendor relationship that covers both the technology platform and the attestation itself — a model that compresses time-to-certification from months to weeks.\n\nThoropass's platform provides automated evidence collection connected to cloud infrastructure (AWS, GCP, Azure), CI/CD pipelines, identity providers, and SaaS tools. Customers get real-time compliance posture monitoring, policy management, vendor risk assessment, and audit readiness dashboards. Because Thoropass employs its own AICPA-accredited auditors, customers do not need to separately engage a Big Four or mid-market accounting firm to complete their SOC 2 audit — the platform and audit are delivered as a unified product. This integration dramatically reduces coordination overhead and audit preparation costs.\n\nThoropass has raised $98 million in total funding, including a $50 million Series C in January 2024, and reported $60.4 million in annual revenue for 2024 with a team of 232 employees. The company has earned G2 Leader recognition for Summer 2025 in the compliance management category and serves hundreds of technology companies that must maintain certifications as a condition of enterprise sales cycles. As compliance requirements expand under frameworks like FedRAMP and emerging AI governance standards, Thoropass is positioned to extend its automation-first model into new regulatory domains.
In talks to raise $2B at $50B valuation in Apr 2026 (Thrive, a16z, Nvidia). $2B+ ARR; revenue projected >$6B by EOY 2026. Used by 50%+ of Fortune 500.
About
Cursor is an AI-first code editor founded in 2022 by a small team of MIT researchers, built as a fork of Visual Studio Code with native large-language-model intelligence woven directly into the editing experience. Its mission is to make software engineers dramatically more productive by embedding AI reasoning into every layer of the IDE — from autocomplete to multi-file edits to natural-language code generation — rather than bolting AI on as an afterthought.\n\nThe platform centers on a VSCode-compatible editor that developers can adopt with zero workflow disruption, layering in features like Tab (predictive multi-line completion), Chat (context-aware in-editor assistant), and Composer (autonomous multi-file refactoring agent). Cursor reads and indexes entire codebases, allowing it to propose changes that span dozens of files coherently. It supports all major languages, integrates with existing extensions, and lets teams configure which underlying model — GPT-4o, Claude, or others — powers suggestions. Fortune 500 engineering teams adopt it alongside individual developers, and it is used by more than half of Fortune 500 companies.\n\nCursor reached $2 billion in annualized recurring revenue by early 2026 and raised at a $29.3 billion valuation, cementing its position as the dominant commercial AI coding tool. The company raised $2.3 billion in total funding and is widely regarded as the category-defining product in agentic IDE software, outpacing GitHub Copilot on developer mindshare metrics in multiple surveys.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.